Market: NASD |
Currency: USD
Address: 7921 Southpark Plaza
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
📈 Vivos Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$4.00
-
Upside/Downside from Analyst Target:
-14.71%
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2025-11-14
-
EPS Estimate:
-0.48
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2023 |
- |
$0.040000 |
- |
2023-10-27 |
- |
Stock split |
Total Amount for 2023: $0.040000 |
📅 Earnings & EPS History for Vivos Therapeutics, Inc.
Date | Reported EPS |
---|
2025-11-13 (estimated upcoming) | - |
2025-08-19 | -0.55 |
2025-05-15 | -0.45 |
2025-03-31 | -0.28 |
2024-11-14 | -0.4 |
2024-08-14 | -0.6 |
2024-05-14 | -1.63 |
2024-03-28 | -2.76 |
2023-11-14 | -3.08 |
2023-08-16 | -3.89 |
2023-06-08 | 1.49 |
2023-03-30 | -5 |
2022-12-20 | -6.5 |
2022-05-16 | -8.01 |
2022-03-31 | -7.31 |
2021-11-15 | -6.5 |
2021-08-12 | -4.75 |
2021-05-17 | -4.75 |
2021-03-25 | -15.47 |
📰 Related News & Research
No related articles found for "vivos therapeutics".